A retrospective comparative study of prednisolone use in antagonist co-treated assisted reproductive technology cycles for patients with good prognosis

ÖZMEN B., Pabuccu E. G., ŞÜKÜR Y. E., Ulubasoglu H., Ates C., SÖNMEZER M., ...Daha Fazla

TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, cilt.15, sa.3, ss.147-151, 2018 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.4274/tjod.12244
  • Dergi Adı: TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.147-151
  • Anahtar Kelimeler: Assisted reproductive technology, glucocorticoid, gonadotropin-releasing hormone antagonist, peri-implantation period, IN-VITRO FERTILIZATION, EMBRYO TRANSFER PATIENTS, PREGNANCY RATE, RECURRENT MISCARRIAGE, SPERM INJECTION, IMPLANTATION, PLACEBO, IMMUNOSUPPRESSION, IMPROVEMENT, FAILURE
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: To investigate the impact of peri-implantation prednisolone use and its duration in antagonist co-treated assisted reproductive technology (ART) cycles of patients with good prognosis.